文献速递消化内镜消化道肿瘤与早癌

传统锯齿状腺瘤的基线特征与纵向结局:一项队列研究

Baseline Characteristics and Longitudinal Outcomes of Traditional Serrated Adenomas: A Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-10-12

该回顾性队列研究纳入1999至2018年美国退伍军人中853例基线传统锯齿状腺瘤(TSA)患者,随访共2044人年,发现11例结直肠癌(CRC)和1例CRC死亡,累积CRC发病率为1.34%(95%CI 0.67%-2.68%),累积CRC死亡率为0.12%(95%CI 0.00%-0.35%);TSA患者CRC风险显著高于基线结肠镜正常者(HR 3.70,95%CI 1.63-8.41),与基线常规进展期腺瘤者相似(HR 0.86,95%CI 0.45-1.64)。

要点

  • TSA患者累积CRC发病率为1.34%(95%CI 0.67%-2.68%),累积CRC死亡率为0.12%(95%CI 0.00%-0.35%)。
  • 378例接受至少1次监测结肠镜的TSA患者中,65.1%在随访中发现高风险肿瘤。
  • TSA患者CRC风险显著高于基线结肠镜正常者(HR 3.70,95%CI 1.63-8.41),与基线常规进展期腺瘤者相似(HR 0.86,95%CI 0.45-1.64)。

核心结论

  • TSA患者具有较高的CRC累积发病率,随访监测结肠镜时发生其他高风险肿瘤的风险也较高。
  • 这些数据强调了当前推荐在TSA诊断后密切结肠镜监测的重要性。

研究设计与样本

  • 回顾性队列研究,纳入1999年至2018年美国退伍军人中年龄≥18岁、至少有1个TSA的患者。
  • 共识别853例基线TSA患者;74%年龄≥60岁,96%为男性,14%为黑人,73%为非西班牙裔白人,约64%为当前或既往吸烟者。
  • 随访至CRC诊断、死亡或研究结束(2018年12月31日),总随访2044人年。
  • 进展期肿瘤定义为CRC或伴有高级别异型增生、绒毛状组织学或大小≥1 cm的腺瘤。

主要发现

  • 随访期间发生11例CRC和1例CRC死亡。
  • 累积CRC发病率为1.34%(95%CI 0.67%-2.68%),累积CRC死亡率为0.12%(95%CI 0.00%-0.35%)。
  • 378例接受至少1次监测结肠镜的TSA患者中,65.1%在随访中发现高风险肿瘤。
  • TSA患者CRC发病率显著高于基线结肠镜正常对照组(HR 3.70,95%CI 1.63-8.41)。
  • TSA患者CRC发病率与基线常规进展期腺瘤对照组相似(HR 0.86,95%CI 0.45-1.64)。

临床怎么用

  • 作者认为这些数据强调了当前推荐在TSA诊断后密切结肠镜监测的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Traditional serrated adenomas (TSAs) may confer increased risk for colorectal cancer (CRC). Our objective with this study was to examine clinical characteristics and long-term outcomes associated with TSA diagnosis. METHODS: We conducted a retrospective cohort study of U.S. Veterans ≥18 years of age with ≥1 TSA between 1999 and 2018. Baseline characteristics, colonoscopy findings, and diagnosis of incident and fatal CRC were abstracted. Advanced neoplasia was defined by CRC or adenoma with high-grade dysplasia, villous histology, or size ≥1 cm. Follow-up was through CRC diagnosis, death, or end of study (December 31, 2018). RESULTS: A total of 853 Veterans with a baseline TSA were identified; 74% were ≥60 years of age, 96% were men, 14% were Black, and 73% were non-Hispanic White. About 64% were current or former smokers. Over 2044 total person-years at follow-up, there were 11 incident CRC cases and 1 CRC death. Cumulative CRC incidence was 1.34% (95% confidence interval [CI], 0.67%-2.68%), and cumulative CRC death was 0.12% (95% CI, 0.00%-0.35%). Among the subset of 378 TSA patients with ≥1 surveillance colonoscopy, 65.1% had high-risk neoplasia on follow-up. CRC incidence among TSA patients was significantly higher than in a comparison cohort of patients with normal baseline colonoscopy at baseline (hazard ratio, 3.70; 95% CI, 1.63-8.41) and similar to a comparison cohort with baseline conventional advanced adenoma (hazard ratio, 0.86; 95% CI, 0.45-1.64). CONCLUSION: Individuals with TSA have substantial risk for CRC based on their cumulative CRC incidence, as well as significant risk of developing other high-risk neoplasia at follow-up surveillance colonoscopy. These data underscore importance of current recommendations for close colonoscopy surveillance after TSA diagnosis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Trivedi M, Godil S, Demb J, et al. Baseline Characteristics and Longitudinal Outcomes of Traditional Serrated Adenomas: A Cohort Study. Clin Gastroenterol Hepatol. 2022. PMID: 36243354. doi:10.1016/j.cgh.2022.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。